Neuropeptide Y and CRH in Major Depressive Disorder (MDD)

被引：0
|
作者：
Mathe, Aleksander A. [1 ]
机构：
[1] Karolinska Inst, Stockholm, Sweden
来源：
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE | 2013年 / 17卷
关键词：
CORTICOTROPIN-RELEASING HORMONE; CEREBROSPINAL-FLUID; RAT;
D O I：
暂无
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：12 / 12
页数：1
相关论文
共 50 条
  • [1] Plasma neuropeptide Y in patients with major depressive disorder
    Hashimoto, H
    Onishi, H
    Koide, S
    Kai, T
    Yamagami, S
    [J]. NEUROSCIENCE LETTERS, 1996, 216 (01) : 57 - 60
  • [2] Face processing in major depressive disorder (MDD)
    Keenan, JP
    Kamwisher, NG
    Pascual-Leone, A
    [J]. NEUROLOGY, 1998, 50 (04) : A46 - A47
  • [3] Relationship Between Major Depressive Disorder (Mdd) Symptoms and Mdd Heterogeneity
    Huang, Lianyun
    Tang, Sonja
    Krebs, Morten Dybdahl
    Schork, Andrew J.
    Werge, Thomas M.
    Dahl, Andy
    Zuber, Verena
    Cai, Na
    [J]. GENETIC EPIDEMIOLOGY, 2021, 45 (07) : 761 - 761
  • [4] Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD)
    Jindal, Manav
    Chhetri, Aakash
    Ludhiadch, Abhilash
    Singh, Paramdeep
    Peer, Sameer
    Singh, Jawahar
    Brar, Rahatdeep Singh
    Munshi, Anjana
    [J]. MOLECULAR NEUROBIOLOGY, 2024, 61 (06) : 3427 - 3440
  • [5] MAJOR DEPRESSIVE DISORDER (MDD) IN ESRD: AN IMPACTFUL COMORBIDITY
    Sundaresh, Shyam
    Meyer, B. Robert
    [J]. JOURNAL OF GENERAL INTERNAL MEDICINE, 2020, 35 (SUPPL 1) : S505 - S505
  • [6] Neuroimaging Genomics a Predictor of Major Depressive Disorder (MDD)
    Manav Jindal
    Aakash Chhetri
    Abhilash Ludhiadch
    Paramdeep Singh
    Sameer Peer
    Jawahar Singh
    Rahatdeep Singh Brar
    Anjana Munshi
    [J]. Molecular Neurobiology, 2024, 61 : 3427 - 3440
  • [7] Intranasal administration of neuropeptide Y; development of a novel treatment for major depressive disorder
    Mathe, A. A.
    Berg, E.
    Michaneck, M.
    Charney, D. S.
    Murrough, J. W.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S139 - S140
  • [8] A Randomized Controlled Trial of Intranasal Neuropeptide Y in Patients With Major Depressive Disorder
    Mathe, Aleksander A.
    Michaneck, Miranda
    Berg, Elisabeth
    Charney, Dennis S.
    Murrough, James W.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2020, 23 (12): : 783 - 790
  • [9] Plasma Neuropeptide Y Levels in Medication Naive Adolescents with Major Depressive Disorder
    Gulec, Medine Yazici
    Ozalmete, Ozlem Albayrak
    Ozturk, Mucahit
    Gulec, Huseyin
    Sayar, Kemal
    Kose, Samet
    [J]. KLINIK PSIKOFARMAKOLOJI BULTENI-BULLETIN OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 20 (02): : 132 - 138
  • [10] Cognitive domains affected by major depressive disorder (MDD)
    Baune, B.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2016, 26 : S757 - S757
12345